369 related articles for article (PubMed ID: 26041300)
21. In vivo protection by broadly neutralizing HIV antibodies.
van Gils MJ; Sanders RW
Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020
[TBL] [Abstract][Full Text] [Related]
22. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.
Mascola JR; Stiegler G; VanCott TC; Katinger H; Carpenter CB; Hanson CE; Beary H; Hayes D; Frankel SS; Birx DL; Lewis MG
Nat Med; 2000 Feb; 6(2):207-10. PubMed ID: 10655111
[TBL] [Abstract][Full Text] [Related]
23. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.
Bomsel M; Tudor D; Drillet AS; Alfsen A; Ganor Y; Roger MG; Mouz N; Amacker M; Chalifour A; Diomede L; Devillier G; Cong Z; Wei Q; Gao H; Qin C; Yang GB; Zurbriggen R; Lopalco L; Fleury S
Immunity; 2011 Feb; 34(2):269-80. PubMed ID: 21315623
[TBL] [Abstract][Full Text] [Related]
24. Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus.
Liu J; Ghneim K; Sok D; Bosche WJ; Li Y; Chipriano E; Berkemeier B; Oswald K; Borducchi E; Cabral C; Peter L; Brinkman A; Shetty M; Jimenez J; Mondesir J; Lee B; Giglio P; Chandrashekar A; Abbink P; Colantonio A; Gittens C; Baker C; Wagner W; Lewis MG; Li W; Sekaly RP; Lifson JD; Burton DR; Barouch DH
Science; 2016 Sep; 353(6303):1045-1049. PubMed ID: 27540005
[TBL] [Abstract][Full Text] [Related]
25. Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1.
Lin A; Balazs AB
Retrovirology; 2018 Oct; 15(1):66. PubMed ID: 30285769
[TBL] [Abstract][Full Text] [Related]
26. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L
Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321
[TBL] [Abstract][Full Text] [Related]
27. Fc receptor but not complement binding is important in antibody protection against HIV.
Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
[TBL] [Abstract][Full Text] [Related]
28. Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.
Shingai M; Donau OK; Plishka RJ; Buckler-White A; Mascola JR; Nabel GJ; Nason MC; Montefiori D; Moldt B; Poignard P; Diskin R; Bjorkman PJ; Eckhaus MA; Klein F; Mouquet H; Cetrulo Lorenzi JC; Gazumyan A; Burton DR; Nussenzweig MC; Martin MA; Nishimura Y
J Exp Med; 2014 Sep; 211(10):2061-74. PubMed ID: 25155019
[TBL] [Abstract][Full Text] [Related]
29. Mucosal application of the broadly neutralizing antibody 10-1074 protects macaques from cell-associated SHIV vaginal exposure.
Suphaphiphat K; Desjardins D; Lorin V; Dimant N; Bouchemal K; Bossevot L; Galpin-Lebreau M; Dereuddre-Bosquet N; Mouquet H; Le Grand R; Cavarelli M
Nat Commun; 2023 Oct; 14(1):6224. PubMed ID: 37803011
[TBL] [Abstract][Full Text] [Related]
30. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.
Egan MA; Chong SY; Megati S; Montefiori DC; Rose NF; Boyer JD; Sidhu MK; Quiroz J; Rosati M; Schadeck EB; Pavlakis GN; Weiner DB; Rose JK; Israel ZR; Udem SA; Eldridge JH
AIDS Res Hum Retroviruses; 2005 Jul; 21(7):629-43. PubMed ID: 16060834
[TBL] [Abstract][Full Text] [Related]
31. Broadly neutralizing antibody-mediated protection against simian-HIV infection among macaques with vaginal sexually transmitted infections.
Garber DA; Guenthner P; Zhao C; Mitchell J; Ellis S; Jia H; Manganare M; Gazumyan A; Seaman MS; Vishwanathan SA; Heneine W; McNicholl JM
AIDS; 2023 Apr; 37(5):723-731. PubMed ID: 36625252
[TBL] [Abstract][Full Text] [Related]
32. Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin.
Rasmussen RA; Montefiori DC; Robinson HL; McClure HM; Ruprecht RM
J Infect Dis; 2001 Dec; 184(12):1603-7. PubMed ID: 11740737
[TBL] [Abstract][Full Text] [Related]
33. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.
Baba TW; Liska V; Hofmann-Lehmann R; Vlasak J; Xu W; Ayehunie S; Cavacini LA; Posner MR; Katinger H; Stiegler G; Bernacky BJ; Rizvi TA; Schmidt R; Hill LR; Keeling ME; Lu Y; Wright JE; Chou TC; Ruprecht RM
Nat Med; 2000 Feb; 6(2):200-6. PubMed ID: 10655110
[TBL] [Abstract][Full Text] [Related]
34. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
Sun Z; Li J; Hu X; Shao Y; Zhang MY
Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
[TBL] [Abstract][Full Text] [Related]
35. Neutralizing antibodies administered before, but not after, virulent SHIV prevent infection in macaques.
Foresman L; Jia F; Li Z; Wang C; Stephens EB; Sahni M; Narayan O; Joag SV
AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1035-43. PubMed ID: 9718118
[TBL] [Abstract][Full Text] [Related]
36. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies.
Ferrantelli F; Rasmussen RA; Buckley KA; Li PL; Wang T; Montefiori DC; Katinger H; Stiegler G; Anderson DC; McClure HM; Ruprecht RM
J Infect Dis; 2004 Jun; 189(12):2167-73. PubMed ID: 15181562
[TBL] [Abstract][Full Text] [Related]
37. Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection.
Yamamoto T; Lynch RM; Gautam R; Matus-Nicodemos R; Schmidt SD; Boswell KL; Darko S; Wong P; Sheng Z; Petrovas C; McDermott AB; Seder RA; Keele BF; Shapiro L; Douek DC; Nishimura Y; Mascola JR; Martin MA; Koup RA
Sci Transl Med; 2015 Jul; 7(298):298ra120. PubMed ID: 26223303
[TBL] [Abstract][Full Text] [Related]
38. Vector-mediated antibody gene transfer for infectious diseases.
Schnepp BC; Johnson PR
Adv Exp Med Biol; 2015; 848():149-67. PubMed ID: 25757620
[TBL] [Abstract][Full Text] [Related]
39. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.
Shibata R; Igarashi T; Haigwood N; Buckler-White A; Ogert R; Ross W; Willey R; Cho MW; Martin MA
Nat Med; 1999 Feb; 5(2):204-10. PubMed ID: 9930869
[TBL] [Abstract][Full Text] [Related]
40. Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates.
Santra S; Seaman MS; Xu L; Barouch DH; Lord CI; Lifton MA; Gorgone DA; Beaudry KR; Svehla K; Welcher B; Chakrabarti BK; Huang Y; Yang ZY; Mascola JR; Nabel GJ; Letvin NL
J Virol; 2005 May; 79(10):6516-22. PubMed ID: 15858035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
